COVID-19 in a region of Cameroon hit by armed conflict

Pan Afr Med J. 2022 Jan 12:41:32. doi: 10.11604/pamj.2022.41.32.32587. eCollection 2022.

Abstract

Introduction: the emergence of more transmissible SARS-CoV-2 variants like Delta and Omicron have triggered the next wave of COVID-19 in many parts of the world. Here we report a surge in COVID-19 cases and deaths in the Northwest (NW) Region of Cameroon, which is plagued with low immunization coverage and armed conflict.

Methods: a cross-sectional study was conducted in September 2021 and data on COVID-19 cases and vaccination were reviewed from the Ministry of Health database from January 1st, 2020 to September 4th, 2021. The security situation of the region was obtained from the districts and regional health managers. Data were analyzed with MS Excel and results presented as trends and proportions.

Results: since the onset of COVID-19 pandemic, there is an increasing prevalence in cases in the NW. Between epidemiological week 34-35 of 2021, there was a surge in COVID-19 cases in the NW. More than 70% of all COVID-19 related deaths reported in the country during epidemiological week-35 were recorded in this region. Despite this high mortality, COVID-19 vaccine uptake remains very low in the region. Indeed, just 0.6% of the 962,036-target population 18-years and above are fully immunized after 6-months of vaccination.

Conclusion: though the country´s epi-curve does not suggest a third wave currently, the NW is experiencing a steady COVID-19 case surge amid insecurity and the circulation of the Delta variant. There is therefore a need to adopt innovative strategies to improve immunization and strengthen other SARS-CoV-2 preventive measures in this region.

Keywords: COVID-19; Cameroon; Northwest Region; armed conflict; immunization; surge.

MeSH terms

  • Armed Conflicts
  • COVID-19 Vaccines
  • COVID-19* / epidemiology
  • Cameroon / epidemiology
  • Cross-Sectional Studies
  • Humans
  • Pandemics / prevention & control
  • SARS-CoV-2*

Substances

  • COVID-19 Vaccines

Supplementary concepts

  • SARS-CoV-2 variants